Even as it feels like everything only continues to get more expensive, Medicare recipients could be in for a surprise with a ...

In contrast, industry giant UnitedHealth Group grew more aggressively in Medicare this year—but that growth came with soaring costs and disappointing results. Its stock has lost nearly half its value, ...

Medicare Part B premiums may jump 11.6% in 2026 to $206.50, impacting Social Security benefits. Here's what seniors need to ...

In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's ...

U.S. Rep. Maggie Goodlander signed onto a letter alongside 41 other U.S. representatives asking Dr. Mehmet Oz, administrator ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

A new study reveals that Medicare and older adults are spending $4.4 billion a year on medical services that offer low or no ...

Medicare Advantage stocks rise as Wolfe Research highlights easier 2026 CAHPS cutpoints, that can boost the companies' Star ...

Top Biden officials turned to Arnold Ventures and the Commonwealth Fund to advise them on policy and provided them with access at private dinners.

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

Dave Ramsey explains Medicare and Medicaid, highlighting differences and eligibility. Trump launches health tracking system ...